What is the current Obesity Intervention Devices market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Obesity Intervention Devices market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Obesity Intervention Devices market?

Rising obesity rates and increasing demand for minimally invasive procedures drive the market.

What are the major challenges facing the Obesity Intervention Devices market?

High costs and limited reimbursement options pose significant challenges to market growth.

Which regions are expected to lead the Obesity Intervention Devices market?

North America and Europe are expected to dominate the market due to high obesity rates.

Who are the top companies in the Obesity Intervention Devices market?

Medtronic, Ethicon, and Apollo Endosurgery are among the leading market players.

What future opportunities exist in the Obesity Intervention Devices market?

Emerging markets and innovative technologies offer significant opportunities for growth.

How will technology impact the Obesity Intervention Devices market future outlook?

Advances in robotics and artificial intelligence will drive innovation and growth.

What is the current regulatory landscape for the Obesity Intervention Devices market?

Stringent regulations and safety standards govern the market, ensuring device efficacy and safety.

Obesity Intervention Devices Expansion Opportunities & Forecast Analysis 2033

Obesity Intervention Devices by Application (Hospitals, Gastroenterology clinics, Ambulatory Surgical Centers), by Type (Gastric Bands, Electrical Stimulation System, Gastric Balloon System, Gastric Emptying System, Appetite Suppressors), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $8.5 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $8.5 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Obesity Intervention Devices Market Size | CAGR 10.2 Forecast 2033

Obesity Intervention Devices Expansion Opportunities & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $8.5 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $8.5 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Obesity Intervention Devices Market Overview

The Obesity Intervention Devices market is a crucial sector that focuses on the development and implementation of medical devices designed to treat obesity. As the global obesity epidemic continues to grow, the Obesity Intervention Devices market size is estimated to be around $1.4 billion, with a growth outlook that is increasingly positive. The market forecast suggests a significant expansion, driven by rising demand for effective obesity treatment solutions, with a compound annual growth rate (CAGR) of 10.3% during the forecast period from 2026 to 2033. This industry expansion is largely driven by technological advancements in medical devices, changing consumer behavior towards health and wellness, and regulatory support for innovative treatments. The scope of this market encompasses a range of devices, including gastric bands, gastric balloons, and electrical stimulation devices, among others.

Loading chart…

Key forces shaping the Obesity Intervention Devices industry include technology shifts towards minimally invasive procedures, regulations that encourage innovation while ensuring safety, and consumer behavior that increasingly seeks effective and sustainable weight loss solutions. The largest region for Obesity Intervention Devices is currently North America, followed by Europe, while the fastest-growing region is expected to be Asia-Pacific, driven by rising obesity rates and increasing healthcare expenditure. As the market continues to evolve, understanding these dynamics will be crucial for stakeholders, including manufacturers, healthcare providers, and policymakers, to navigate the opportunities and challenges in the Obesity Intervention Devices market.

Report Overview

Report Attribute	Details
Market size value in 2025	8.50 million
Revenue forecast in 2033	18.49 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; EnteroMedics; Apollo Endosurgery; Cousin Biotech; Aspire Bariatrics; Obalon Therapeutics; GI Dynamics; Johnson and Johnson; Spatz FGIA; Gore Medical; ReShape Lifesciences
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Obesity Intervention Devices market is poised for significant growth, driven by rising obesity rates and an increasing demand for effective treatment options. This section provides an in-depth analysis of the market dynamics, including growth drivers, restraints, opportunities, and challenges.

Growth Drivers2 items

Advances in technology have led to the development of minimally invasive and non-invasive Obesity Intervention Devices, improving patient outcomes and reducing recovery time, thereby driving the growth of the Obesity Intervention Devices market size.

Government initiatives and awareness campaigns have increased the adoption of Obesity Intervention Devices, further fueling the growth forecast of the market.

Restraints2 items

High costs associated with Obesity Intervention Devices and procedures may limit adoption, particularly in developing economies, hindering the Obesity Intervention Devices market size.

Stringent regulatory requirements and the need for clinical trials may slow down the approval process for new Obesity Intervention Devices, affecting the overall growth forecast.

Opportunities2 items

Emerging markets, such as Asia-Pacific and Latin America, offer significant opportunities for Obesity Intervention Devices manufacturers due to rising obesity rates and increasing healthcare expenditure.

The development of innovative, patient-centric Obesity Intervention Devices can help companies differentiate themselves and gain a competitive edge in the market, driving the Obesity Intervention Devices market forward.

Challenges2 items

The Obesity Intervention Devices market faces intense competition, with numerous players vying for market share, making it challenging for companies to maintain their position and drive growth.

Managing supply chain disruptions and maintaining profitability in a price-sensitive market are significant challenges for Obesity Intervention Devices manufacturers, affecting the overall growth forecast of the market.

Market Segmentation

Loading chart…

The Application segment of the Obesity Intervention Devices market refers to the various uses of these devices in treating obesity. This segment is crucial in understanding the Obesity Intervention Devices segmentation and its impact on the market size. The application segment includes subtypes such as gastric bypass, gastric banding, and gastric ballooning, among others. Each of these subtypes contributes to the overall market size, with some being more prominent than others. For instance, gastric bypass is a widely used application, driving a significant portion of the market size.

The Type segment of the Obesity Intervention Devices market categorizes devices based on their functionality and characteristics. This segment is vital in market taxonomy as it helps analyze the market size and trends. The type segment includes subtypes such as adjustable gastric bands, gastric electrical stimulators, and intragastric balloons, among others. Each subtype has its own market share, with some being more popular than others. Understanding these subtypes is essential to grasp the overall Obesity Intervention Devices market size and trends.

Obesity Intervention Devices Segmentation Breakdown10 items

Application

Hospitals

Gastroenterology clinics

Ambulatory Surgical Centers

Type

Gastric Bands

Electrical Stimulation System

Gastric Balloon System

Gastric Emptying System

Appetite Suppressors

Regional Insights

Loading chart…

The Obesity Intervention Devices market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of obesity intervention devices, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a high prevalence of obesity, advanced infrastructure, and a mature ecosystem. Europe is driven by a growing demographic of obese individuals, increasing adoption of minimally invasive procedures, and supportive policies. Asia Pacific is fueled by a large and growing population, rising awareness of obesity-related health issues, and improving infrastructure. Latin America and Middle East & Africa are driven by increasing investments in healthcare, growing demand for obesity intervention devices, and expanding distribution networks.

The regional forecast indicates that Asia Pacific will experience the highest growth rate, driven by emerging economies such as China and India. Latin America and Middle East & Africa are expected to witness moderate growth, while North America and Europe will experience steady growth due to established markets and high ecosystem maturity.

Competitive Landscape

The Obesity Intervention Devices market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Obesity Intervention Devices competitive landscape is characterized by high competition, with companies focusing on differentiation through product innovation and strategic partnerships. Companies are leveraging pricing, distribution, and product innovation to gain a competitive edge in the market.

Common strategies employed by companies in this market include M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must focus on strategic initiatives that drive growth and differentiation.

Medtronic: regional expansion

EnteroMedics: premium pricing

Apollo Endosurgery: innovation pipeline

Cousin Biotech: local manufacturing

Aspire Bariatrics: vertical integration

Obalon Therapeutics: OEM tie-ups

Key Obesity Intervention Devices Companies11 items

Medtronic

EnteroMedics

Apollo Endosurgery

Cousin Biotech

Aspire Bariatrics

Obalon Therapeutics

GI Dynamics

Johnson and Johnson

Spatz FGIA

Gore Medical

ReShape Lifesciences

Market Ecosystem

The Obesity Intervention Devices ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers, midstream integrators and manufacturers, to downstream channels and end users. This ecosystem is characterized by the creation and capture of value through the development, production, and distribution of devices designed to combat obesity. The boundaries of this ecosystem are defined by the flow of goods, services, and information from raw material suppliers to end users, with various intermediaries playing crucial roles in the value chain analysis.

Raw material suppliers — providing components for device manufacturing

OEMs / manufacturers — designing and producing Obesity Intervention Devices

Technology providers — developing innovative solutions for obesity treatment

System integrators / EPCs — integrating devices into comprehensive treatment systems

Distributors / channel partners — delivering devices to healthcare providers and consumers

Service providers / after-sales — offering maintenance, support, and training services

Regulators/standards bodies — establishing guidelines and approvals for device safety and efficacy

Within the Obesity Intervention Devices ecosystem, control points are primarily held by regulators and standards bodies, as their approvals and guidelines significantly influence device adoption. Dependency risks arise from input constraints, such as component shortages, and the need for compliance with stringent regulatory standards. Switching costs and partnerships are also critical, as manufacturers must often collaborate with healthcare providers and insurers to ensure device reimbursement and adoption. Furthermore, the ecosystem differs by region, with varying levels of healthcare infrastructure, regulatory requirements, and consumer awareness, necessitating tailored strategies for different markets.

Recent Industry Insights

The Obesity Intervention Devices market has witnessed significant developments over the last 12-18 months, shaping the future of Obesity Intervention Devices industry trends. Notable partnerships and mergers & acquisitions have been observed, such as collaborations between medical device manufacturers and healthcare providers to enhance the accessibility of obesity intervention solutions.

Furthermore, there have been several product launches and technological advancements in the field, focusing on minimally invasive procedures and wearable devices that monitor and manage weight. Regulatory changes have also played a crucial role in driving the market forward, with an increased emphasis on patient safety and efficacy. As a result, the Obesity Intervention Devices industry trends are expected to continue evolving, driven by innovation and strategic expansions.

Analyst Overview

As the Lead Analyst for this study, I conclude that the Obesity Intervention Devices market outlook is highly attractive, driven by the rising prevalence of obesity and associated comorbidities. The competitive intensity is moderate, with key players investing in research and development to improve device efficacy and safety. The long-term outlook is promising, with an increasing demand for minimally invasive and non-invasive interventions.

The innovation landscape is rapidly evolving, with advancements in bariatric surgery and endoluminal devices. However, the demand–supply balance is a concern, as the market is experiencing a shortage of skilled professionals to perform these interventions. Key risk factors include regulatory challenges, reimbursement issues, and potential device-related complications. Overall, the Obesity Intervention Devices market is poised for growth, but stakeholders must navigate these challenges to capitalize on emerging opportunities.

11 items

1. Executive Summary

2. Obesity Intervention Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Obesity Intervention Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Obesity Intervention Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Gastroenterology clinics

6.1.3. Ambulatory Surgical Centers

6.2. Global Obesity Intervention Devices Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.2.1. Gastric Bands

6.2.2. Electrical Stimulation System

6.2.3. Gastric Balloon System

6.2.4. Gastric Emptying System

6.2.5. Appetite Suppressors

6.3. Global Obesity Intervention Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Obesity Intervention Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Obesity Intervention Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Type

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Type

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Type

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Type

8. Global Obesity Intervention Devices Market Competition by Key Manufacturers

8.1. Global Obesity Intervention Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Obesity Intervention Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medtronic

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. EnteroMedics

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Apollo Endosurgery

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Cousin Biotech

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Aspire Bariatrics

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Obalon Therapeutics

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. GI Dynamics

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Johnson and Johnson

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Spatz FGIA

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Gore Medical

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. ReShape Lifesciences

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Obesity Intervention Devices Market

Figure 4: Global Obesity Intervention Devices Market: Drivers

Figure 5: Global Obesity Intervention Devices Market: Challenges

Figure 6: Global Obesity Intervention Devices Market: Trends

Figure 7: Global Obesity Intervention Devices Market: Opportunity

Figure 8: Global Obesity Intervention Devices Market: Restraint

Figure 9: Global Obesity Intervention Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Type

Figure 13: Global Market Share (%) By Type (2024)

Figure 14: Global Obesity Intervention Devices Market Value (USD Million) By Region

Figure 15: Global Obesity Intervention Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Type

Figure 21: Global Market Share (%) By Type (2032)

Figure 22: Global Obesity Intervention Devices Market Value (USD Million) By Region

Figure 23: Global Obesity Intervention Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Obesity Intervention Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Obesity Intervention Devices Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 4: Global Obesity Intervention Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Type

Table 8: Global Market Share (%) By Type (2024)

Table 9: Global Obesity Intervention Devices Market Value (USD Million) By Region

Table 10: Global Obesity Intervention Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Type

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Type

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Type

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 26: Global Obesity Intervention Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Obesity Intervention Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Obesity Intervention Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medtronic Basic Information And Sales Area

Table 31: Medtronic. Products Portfolio

Table 32: EnteroMedics Basic Information And Sales Area

Table 33: EnteroMedics. Products Portfolio

Table 34: Apollo Endosurgery Basic Information And Sales Area

Table 35: Apollo Endosurgery. Products Portfolio

Table 36: Cousin Biotech Basic Information And Sales Area

Table 37: Cousin Biotech. Products Portfolio

Table 38: Aspire Bariatrics Basic Information And Sales Area

Table 39: Aspire Bariatrics. Products Portfolio

Table 40: Obalon Therapeutics Basic Information And Sales Area

Table 41: Obalon Therapeutics. Products Portfolio

Table 42: GI Dynamics Basic Information And Sales Area

Table 43: GI Dynamics. Products Portfolio

Table 44: Johnson and Johnson Basic Information And Sales Area

Table 45: Johnson and Johnson. Products Portfolio

Table 46: Spatz FGIA Basic Information And Sales Area

Table 47: Spatz FGIA. Products Portfolio

Table 48: Gore Medical Basic Information And Sales Area

Table 49: Gore Medical. Products Portfolio

Table 50: ReShape Lifesciences Basic Information And Sales Area

Table 51: ReShape Lifesciences. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Type

Table 55: Global Market Share (%) By Type (2032)

Table 56: Global Obesity Intervention Devices Market Value (USD Million) By Region

Table 57: Global Obesity Intervention Devices Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Type

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Type

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Type

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Obesity Intervention Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.50 million
Revenue forecast in 2033	18.49 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; EnteroMedics; Apollo Endosurgery; Cousin Biotech; Aspire Bariatrics; Obalon Therapeutics; GI Dynamics; Johnson and Johnson; Spatz FGIA; Gore Medical; ReShape Lifesciences
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options